$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
News
News
Medical Halo Global Pharmaceutical News_Targeted Drugs_New Anti-Cancer Drugs_Overseas Medical Information_【Medical Halo Global Pharmaceutical】
Domestic price of Erdafitinib
2026-02-01 22:25:32
Check Details
What should I do if I become drug-resistant after taking Erdafitinib?
2026-02-01 22:25:32
Check Details
Erdafitinib is a targeted drug of several generations
2026-02-01 22:25:32
Check Details
Bladder cancer targeted drug Erdafitinib Indian version
2026-02-01 22:25:32
Check Details
Can Erdafitinib cure bladder cancer?
2026-02-01 22:25:32
Check Details
Erdafitinib Liver Cancer
2026-02-01 22:25:32
Check Details
Is Erdafitinib an oral medication?
2026-02-01 22:25:32
Check Details
Is Erdafitinib effective in treating lung cancer?
2026-02-01 22:25:32
Check Details
Where can I buy Erdafitinib in China?
2026-02-01 22:25:32
Check Details
How long does Erdafitinib treatment take to take effect?
2026-02-01 22:25:32
Check Details
How many boxes of Erdafitinib should be taken in a month?
2026-02-01 22:25:32
Check Details
How many times can you take Erdafitinib a year?
2026-02-01 22:25:32
Check Details
1
2
...
316
317
318
319
320
321
322
...
10221
10222
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
Vadadustat: Clinical Evidence and Patient Benefits of an Oral HIF-PHI for CKD-Related Anemia
2
Ponatinib vs. Olverembatinib: A Multidimensional Comparison of Third-Generation BCR-ABL Inhibitors
3
Leflunomide and Ocular Adverse Effects: Risk Awareness and Clinical Guidance
4
Clinical Management of Acquired Resistance to Garsorasib (KRAS G12C Inhibitor)
5
Chemical Structure of Capivasertib: A Novel AKT Inhibitor
6
Avatrombopag (Doptelet): Oral TPO-RA for Multiple Thrombocytopenia Types
7
Capivasertib: An AKT Inhibitor for Breast and Prostate Cancer
8
Gilteritinib (Xospata): Precision Oral Targeted Therapy for FLT3-Mutated AML
9
Macitentan Guide: Dietary Interactions, Contraindications, and Reproductive Safety Protocols
10
Global Update 2026: Selumetinib (KOSELUGO) Expands Indication to Adult NF1-PN and Clinical Management Strategies
11
Lenvatinib Safety Guide: Baseline Assessment & Adverse Reaction Management
12
Donidalorsen (DAWNZERA®) Side Effects and Safety Management Guide